![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, June 18, 2024 5:33:51 PM
Dr Reddy's invested in marketing a new non-drug wearable for pain relief. (Bullish for Electroceuticals).
The Nerivio is priced at $180 and provides 36 days of therapy, per the article. (ActiPatch provides 30 days of therapy for $34.95).
Nerivio's Side Effects, Nausea, Photophobia, and Phonophobia are listed in the 510k Summary #K201824 page 8. (ActiPatch = Zero Side Effects)
The NerivioInfinity Rechargeable did not require any new Clinicals per 510k #K232152, final page, which was submitted 7/19/2023 and Cleared on 11/08/2023.
(ActiPatch will be in a similar situation when they file a 510k for the Rechargeable version, therapeutic elements, electrical waveform, location on the body, treatment instructions, treatment duration, all are the same)
Why don't you go whip up some new 'Fake News' about BIEL to make yourself feel better.
SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results • SNWV • Aug 13, 2024 7:11 AM
Kona Gold Beverages, Inc. Nears Completion of Reverse Merger with New Candidate • KGKG • Aug 12, 2024 10:00 AM
Maybacks Global Entertainment and DigiTrax Entertainment Sign Agreement to Broadcast "Karaoke Cloud" on iDreamCTV • AHRO • Aug 12, 2024 8:45 AM
HealthLynked Partners with RxSpark to Enhance Medication Access and Management for Patients • HLYK • Aug 12, 2024 8:00 AM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM